Barclays’s Globus Medical GMED Stock Holding History

Barclays’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-25,000	Closed	-$1.26M	–	7219
2018 Q2	$1.26M	Buy	+25,000	New	+$1.3M	﹤0.01%	3026

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Barclays's GMED Position: Q2 2026 in Review

Barclays reduced its Globus Medical (GMED) stake by 1.4% in Q2 2026, selling an estimated $72.5K and leaving 59,533 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Barclays first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $68.7M in Q1 2023. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Barclays held 59,533 shares of Globus Medical worth $4.7M as of Q2 2026.
Barclays sold 853 Globus Medical shares in Q2 2026, an estimated $72.5K.
Globus Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1883 holding.
Barclays first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
Barclays's Globus Medical position peaked at $68.7M in Q1 2023.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.